SPECTRUM OF CT FINDINGS IN CLINICALLY SUSPECTED CASES OF MUCORMYCOSIS – A STUDY AT TERTIARY HEALTH-CARE CENTER (RAJINDRA HOSPITAL PATIALA) DURING SECOND WAVE OF COVID PANDEMIC
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i5.43928Keywords:
COVID STATUS, SINONASAL MYCOSIS, RHINOCEREBRAL MUCORMYCOSIS, COMORBIDITY, CAVERNOUS SINUS THROMBOSIS, COMPUTED TOMOGRAPHYAbstract
Objective: Rhinocereberal mucormycosis is an acute, fulminant, and often lethal opportunistic infection typically affecting diabetic or immunocompromised patients. Early diagnosis is vital in these infections because delay in initiation of the treatment can be life-threatening. Computed tomography (CT) with axial and coronal sections is a highly accurate and non-invasive modality to accurately image sinonasal mycosis. The aim of the study was to describe the imaging findings in suspected cases of mucormycosis on CT.
Methods: This study was conducted in Radiodiagnosis Department of Rajindra Hospital, Patiala. The data of 22 patients who were referred for CT with a clinical suspicion of mucormycosis were collected and all these patients were followed up to know about the prognosis of the disease.
Results: In our study, there were 54.60% females and 45.40% males. Maximum number of patients (45.45%) belonged to 40–49 year age group. Diabetes mellitus was found to be the most commonly (90.90%) found comorbidity followed by hypertension (36.36%). In our study, involvement of unilateral nasal cavity was observed in 36.36% cases. Among the paranasal sinuses, maxillary and ethmoid sinuses were the most commonly involved in 95.45% and 77.27% cases.
Conclusion: Prompt diagnosis and treatment of rhino-orbital mucormycosis are the sine qua non as antifungal drugs and surgical debridement can successfully control the infection and thus reduce the high mortality and morbidity associated with mucormycosis.
Downloads
References
Herrera DA, Dublin AB, Ormsby EL, Aminpour S, Howell LP. Imaging findings of rhinocerebralmucormycosis. Skull Base 2009;19:117-25. doi: 10.1055/s-0028-1096209.
Kauh CY, Nelson CC. Diagnosis and management of orbital mucormycosis. Ophthalmic Pearls (Oculoplastics). Am acad ophthal: EyeNet. 2014:37-9.
Alam A, Chander BN, Sabhikhi GS, Bhatia M. Sinonasalmucormycosis: Diagnosis using computed tomography. Med J Armed Forces India 2003;59:243-5. doi: 10.1016/S0377-1237(03)80018-7, PMID 27407526
Dubey S, Mukherjee D, Sarkar P, Mukhopadhyay P, Barman D, Bandopadhyay M, et al. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum. Diabetes Metab Syndr 2021;15:102267. doi: 10.1016/j.dsx.2021.102267
Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms 2021;9:523. doi: 10.3390/microorganisms9030523, PMID 33806386
Patel A, Kaur H, Xess I, Michael JS, Savio J, Rudramurthy S, et al. A multi-centre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect 2020;26:944.e9-15. doi: 10.1016/j.cmi.2019.11.021
El-Kholy NA, El-Fattah AM, Khafagy YW. Invasive fungal sinusitis in post COVID-19 patients: A new clinical entity. Laryngoscope 2021;131:2652-8. doi: 10.1002/lary.29632, PMID 34009676
Mazzai L, Anglani M, Giraudo C, Martucci M, Cester G, Causin F. Imaging features of rhinocerebralmucormycosis: From onset to vascular complications. Acta Radiol 2021;63:232-44..
Published
How to Cite
Issue
Section
Copyright (c) 2022 DR Amita, Dr Simmi Bhatnagar, Ishita Gupta, Dr Vishav Yadav, Dr Manpreet
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.